KRISTINE M BALL
CIK 1266163 · See Remarks · last filed 2026-06-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
5
Total Filings
26
Lifetime Open-Market Net
-$198.5K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ORKA | Director | — | $69.89 | — | $0 | 2 | 2026-06-03 |
| Atreca, Inc. (BCEL) Delisted | Director | — | $0.15 | — | $0 | 5 | 2023-06-15 |
| Forty Seven, Inc. (FTSV) Delisted | Director | — | — | — | $0 | 2 | 2020-04-07 |
| VYNE Therapeutics Inc. (MNLO) Delisted | See Remarks | 80,300 | — | — | $0 | 6 | 2019-12-16 |
| Relypsa Inc (RLYP) Delisted | Chief Financial Officer & SVP | 0 | — | — | -$198.5K | 11 | 2016-09-02 |
Recent Filings · Page 2 of 3
26 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-08-07 | VYNE Therapeutics Inc. (MNLO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-07-31 | VYNE Therapeutics Inc. (MNLO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-06-14 | Forty Seven, Inc. (FTSV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-12-12 | VYNE Therapeutics Inc. (MNLO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-05-04 | VYNE Therapeutics Inc. (MNLO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-09-02 | Relypsa Inc (RLYP) Delisted | Mixed | −28,110 | -$1.03M | EDGAR |
| 2016-08-17 | Relypsa Inc (RLYP) Delisted | Tax (F) | −1,480 | -$47.2K | EDGAR |
| 2016-06-07 | Relypsa Inc (RLYP) Delisted | Mixed | +1,300 | -$15.6K | EDGAR |
| 2016-03-16 | Relypsa Inc (RLYP) Delisted | Buy (P) | +7,000 | $85.0K | EDGAR |
| 2015-11-10 | Relypsa Inc (RLYP) Delisted | Grant (A) | +6,250 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.